StockData
BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc (BCRX) stock

BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$7.50+0.05 (+0.67%)

Close on Nov 17, 2026Market cap $1.92BP/E –Yield –

BioCryst Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

BioCryst Pharmaceuticals's EV/EBITDA was 4.9× on Apr 30, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20264.9×−16.1
2025Dec 31, 202521.0×–

More BioCryst Pharmaceuticals figures

See a number that looks wrong?